Immucell (ICCC) Current Assets (2010 - 2026)
Immucell's (ICCC) quarterly Current Assets came in at $16.9 million in Q4 2025, up 12.64% YoY from $15.0 million in Q4 2024, and up 0.71% on a QoQ basis from $16.8 million in Q3 2025.
Immucell (ICCC) Current Assets (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Current Assets data on file, last reported at $16.9 million in Q4 2025.
- Quarterly Current Assets rose 12.64% year-over-year to $16.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.9 million (up 12.64% YoY) and the FY2025 annual result came in at $16.9 million, up 12.64% from the prior year.
- Current Assets improved to $16.9 million in Q4 2025, from $16.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $18.3 million in Q1 2022 to a low of $10.8 million in Q2 2024.
- A 5-year average of $14.5 million and a median of $15.3 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets surged 61.77% — and 2023, when it slumped 36.83%.
- Tracing ICCC's Current Assets over 5 years: stood at $16.3 million in 2021, then dropped by 13.96% to $14.0 million in 2022, then slipped by 18.04% to $11.5 million in 2023, then surged by 31.15% to $15.0 million in 2024, then climbed by 12.64% to $16.9 million in 2025.
- The last three Current Assets figures came in at $16.9 million (Q4 2025), $16.8 million (Q3 2025), and $17.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 21.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.08 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 16.83 Mn |
| Jun 30, 2025 | 17.14 Mn |
| Mar 31, 2025 | 15.92 Mn |
| Dec 31, 2024 | 15.04 Mn |
| Sep 30, 2024 | 13.89 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Mar 31, 2024 | 11.35 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Sep 30, 2023 | 11.96 Mn |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 12.25 Mn |
| Dec 31, 2022 | 13.99 Mn |
| Sep 30, 2022 | 16.43 Mn |
| Jun 30, 2022 | 17.33 Mn |
| Mar 31, 2022 | 18.30 Mn |
| Dec 31, 2021 | 16.26 Mn |
| Sep 30, 2021 | 16.08 Mn |
| Jun 30, 2021 | 15.53 Mn |